Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder

被引:26
|
作者
Lupori, Leonardo [1 ,2 ]
Sagona, Giulia [2 ,3 ,4 ]
Fuchs, Claudia [5 ]
Mazziotti, Raffaele [2 ,3 ]
Stefanov, Antonia [2 ]
Putignano, Elena [2 ]
Napoli, Debora [1 ,2 ]
Strettoi, Enrica [2 ]
Ciani, Elisabetta [5 ]
Pizzorusso, Tommaso [1 ,2 ,3 ]
机构
[1] Scuola Normale Super Pisa, BIO SNS Lab, Via Moruzzi 1, I-56124 Pisa, Italy
[2] CNR, Inst Neurosci, Via Moruzzi 1, I-56124 Pisa, Italy
[3] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Area San Salvi Pad 26, I-50135 Florence, Italy
[4] IRCCS Stella Maris Fdn, Dept Dev Neurosci, I-56128 Pisa, Italy
[5] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy
关键词
INTRINSIC SIGNAL; IMPAIRMENT; EXPRESSION; PHENOTYPES; NEURONS; MICE;
D O I
10.1093/hmg/ddz102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CDKL5 deficiency disorder (CDD) is a neurodevelopmental disorder characterized by a severe global developmental delay and early-onset seizures. Notably, patients show distinctive visual abnormalities often clinically diagnosed as cortical visual impairment. However, the involvement of cerebral cortical dysfunctions in the origin of the symptoms is poorly understood. CDD mouse models also display visual deficits, and cortical visual responses can be used as a robust biomarker in CDKL5 mutant mice. A deeper understanding of the circuits underlying the described visual deficits is essential for directing preclinical research and translational approaches. Here, we addressed this question in two ways: first, we performed an in-depth morphological analysis of the visual pathway, from the retina to the primary visual cortex (V1), of CDKL5 null mice. We found that the lack of CDKL5 produced no alteration in the organization of retinal circuits. Conversely, CDKL5 mutants showed reduced density and altered morphology of spines and decreased excitatory synapse marker PSD95 in the dorsal lateral geniculate nucleus and in V1. An increase in the inhibitory marker VGAT was selectively present in V1. Second, using a conditional CDKL5 knockout model, we showed that selective cortical deletion of CDKL5 from excitatory cells is sufficient to produce abnormalities of visual cortical responses, demonstrating that the normal function of cortical circuits is dependent on CDKL5. Intriguingly, these deficits were associated with morphological alterations of V1 excitatory and inhibitory synaptic contacts. In summary, this work proposes cortical circuit structure and function as a critically important target for studying CDD.
引用
收藏
页码:2851 / 2861
页数:11
相关论文
共 50 条
  • [31] mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder
    Gurgone, Antonia
    Pizzo, Riccardo
    Raspanti, Alessandra
    Chiantia, Giuseppe
    Devi, Sunaina
    Comai, Debora
    Morello, Noemi
    Pilotto, Federica
    Gnavi, Sara
    Lupori, Leonardo
    Mazziotti, Raffaele
    Sagona, Giulia
    Putignano, Elena
    Nocentini, Alessio
    Supuran, Claudiu T.
    Marcantoni, Andrea
    Pizzorusso, Tommaso
    Giustetto, Maurizio
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (06) : 877 - 886
  • [32] mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder
    Antonia Gurgone
    Riccardo Pizzo
    Alessandra Raspanti
    Giuseppe Chiantia
    Sunaina Devi
    Debora Comai
    Noemi Morello
    Federica Pilotto
    Sara Gnavi
    Leonardo Lupori
    Raffaele Mazziotti
    Giulia Sagona
    Elena Putignano
    Alessio Nocentini
    Claudiu T. Supuran
    Andrea Marcantoni
    Tommaso Pizzorusso
    Maurizio Giustetto
    Neuropsychopharmacology, 2023, 48 : 877 - 886
  • [33] Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder
    Vossler, David G.
    EPILEPSY CURRENTS, 2022, 22 (06) : 348 - 350
  • [34] Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder
    Tassinari, Marianna
    Mottolese, Nicola
    Galvani, Giuseppe
    Ferrara, Domenico
    Gennaccaro, Laura
    Loi, Manuela
    Medici, Giorgio
    Candini, Giulia
    Rimondini, Roberto
    Ciani, Elisabetta
    Trazzi, Stefania
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [35] Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder
    Varela, Tatiana
    Varela, Debora
    Martins, Gil
    Conceicao, Natercia
    Cancela, M. Leonor
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder
    Tatiana Varela
    Débora Varela
    Gil Martins
    Natércia Conceição
    M. Leonor Cancela
    Scientific Reports, 12
  • [37] A Novel Mouse Model Unveils Protein Deficiency in Truncated CDKL5 Mutations
    Feng, Xue
    Zhu, Zi-Ai
    Wang, Hong-Tao
    Zhou, Hui-Wen
    Liu, Ji-Wei
    Shen, Ya
    Zhang, Yu-Xian
    Xiong, Zhi-Qi
    NEUROSCIENCE BULLETIN, 2025,
  • [38] Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice
    Mazziotti, Raffaele
    Lupori, Leonardo
    Sagona, Giulia
    Gennaro, Mariangela
    Della Sala, Grazia
    Putignano, Elena
    Pizzorusso, Tommaso
    HUMAN MOLECULAR GENETICS, 2017, 26 (12) : 2290 - 2298
  • [39] CDKL5 deficiency disorder: clinical features, diagnosis, and management
    Leonard, Helen
    Downs, Jenny
    Benke, Tim A.
    Swanson, Lindsay
    Olson, Heather
    Demarest, Scott
    LANCET NEUROLOGY, 2022, 21 (06): : 563 - 576
  • [40] Expanding the phenotype of the CDKL5 deficiency disorder: Are seizures mandatory?
    MacKay, Conor I.
    Bick, David
    Prokop, Jeremy W.
    Munoz, Ivan
    Rouse, John
    Downs, Jenny
    Leonard, Helen
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2020, 182 (05) : 1217 - 1222